The Glass-Lined Equipment (GLE) industry is poised for significant growth, driven by multiple factors. GLE protects the ...

HBM Healthcare Investments AG / Key word (s): Quarter Results HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year 03-Jan-2025 / 17:48 CET/CEST Release ...

Anthem Biosciences Limited, an innovation-driven and technology-focused contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug ...

The revenue from operations jumped 43% YoY to ₹291 crore in Q2 FY25, compared to ₹203 crore in the same quarter of the previous year.

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

Investors can bid for up to 27 shares in a single lot, with the company setting a price range of Rs 522-549 per share.

South Korea has designated life sciences and biotechnology as priority areas for growth and leadership. The country is experiencing rapid growth in biotechnology thanks to continuous public and ...

Her expertise is in personal finance and investing, and real estate. An initial public offering (IPO) is the process a private corporation goes through so it can sell shares to investors on a ...

She is passionate about empowering others to protect life's most important assets. Wh... Read Full Bio Ashlee ValentineDeputy Editor, Insurance Ashlee is an insurance editor, journalist and ...

Amy Danise is the managing editor for the insurance section at Forbes Advisor, which encompasses auto, home, renters, life, pet, travel, health and small business insurance. She is a highly ...

We have pieced together accounts from multiple reliable sources to build a picture of everyday life for Nasim and other women, who are currently being held in Evin prison. Many were among the tens ...